Lonza Reports a Strong Third Quarter and Capsugel Integration on Track
Continued strong performance in Q3 2017 for Lonza standalone as expected Both segments on track to deliver full-year tar…
Continued strong performance in Q3 2017 for Lonza standalone as expected Both segments on track to deliver full-year tar…
Site is being acquired from Shire plc and adds early-phase clinical manufacture on the West Coast Capacity includes 1,00…
Lonza has acquired Micro-Macinazione, one of Europe’s leading contract manufacturers providing micronization of active i…
Strong start in Q1 paves way for double-digit organic sales growth for first half year CORE EBIT growth expected to be e…
Lonza and the PolyPeptide Group jointly announced today that PolyPeptide Laboratories Holding (PPL) has entered into a d…
Lonza today announced that its Board of Directors appointed Rodolfo Savitzky as new Chief Financial Officer for Lonza. I…
• Business performance above target – positive start to 2016 with a good momentum continuing into the second quarter •…